A leading Covid-19 vaccine under development in China showed inconclusive outcomes about its level of security, although scientists remain optimistic that the candidate can be among a lineup of efficient vaccines used to eliminate the pandemic.
In early-stage scientific trials, Sinovac Biotech Ltd.’s CoronaVac vaccine was shown to induce antibodies in the body within 28 days of the first immunization, according to outcomes released in the Lancet medical journal today. The level of antibodies, however, were lower than …
Comments
Post a Comment